Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...
Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid ... CoV-2 Omicron XBB1.5 spike antigen as a seasonal ...
In March 2020, AnGes began developing a DNA plasmid vaccine that contains the gene encoding the coronavirus spike protein. Host cells recognize the DNA fragment and transcribe it into an RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback